The China-Europe medical mixed fund has performed well in the past three months, and its performance is extremely excellent. In the complex and changeable market environment, it continues to rise and has been highly recognized by the market. In view of this, it can be seen from the increase of China-Europe medical mixed fund in the past three months that the market is full of confidence in its prospects. However, due to market fluctuations and other factors, the performance of China-Europe medical hybrid fund may not continue to rise. In the next three months, the China-EU medical mixed fund may undergo adjustment and callback, but the overall increase will not be too great. Therefore, in the next three months, China-EU medical mixed funds are still expected to continue to soar, but the increase may not be too great.